Pfizer have developed a new treatment for diabetics - Exubera, an insulin which can be inhaled.
The greatest potential advance in treatment for 80 years which could transform the lives of diabetics but it has been rejected by NICE on grounds of cost.
However, it's benefits are huge. Not only will it bring an end to injections, for some up to five a day; but it will also reduce complications such as heart disease, amputation, blindness and kidney failure.
Therefore, please show your support in asking NICE to reconsider its decision and to look at the overall benefits which would ultimately reduce lifecycle costs whilst improving the lives of millions.